يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Heidi Gillenwater"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
    754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)

    المؤلفون: Haven Garber, Saranya Chumsri, Yazan Migdady, Chul Kim, Erika Hamilton, Jennifer Specht, Babar Bashir, Hirva Mamdani, Heidi Gillenwater, Yeonhee Kim, David R Spigel, Usama Gergis, Hemant S Murthy, Lubna N Chaudhary, Sarah Fitzsimmons, Bishwa J Ganguly, Hajime Hiraragi, Helle Jensen, Mary C Lessig

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2051-1426Test

    الوصول الحر: https://doaj.org/article/22595beb19204c3fae68bc30f71d834eTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

    المؤلفون: Joal D Beane, Yazan Samhouri, Brent A Hanks, John Hyngstrom, Sarah Weiss, Heidi Gillenwater, Yeonhee Kim, J Randolph Hecht, Bishwa J Ganguly, Hajime Hiraragi, Lucy Gong, Navid Nikoo

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2051-1426Test

    الوصول الحر: https://doaj.org/article/131c086eb8404ff79d66b0ec86a836acTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    449 Concurrent ibrutinib enhances T cell function in patients with chronic lymphocytic leukemia (CLL) treated with lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T cell therapy

    المؤلفون: Julie Rytlewski, Leanne Peiser, Jerill Thorpe, Heidi Gillenwater, Ken Ogasawara, Yeonhee Kim, Diana Shpektor, Eniko Papp

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2051-1426Test

    الوصول الحر: https://doaj.org/article/1603585596764915b3aaf112d600f635Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup

    المؤلفون: Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee Joo Chng, Hartmut Goldschmidt, Roman Hajek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosinol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng, Douglas Joshua

    المساهمون: DEPT OF MEDICINE

    المصدر: Taylor & Francis

    العلاقة: Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee Joo Chng, Hartmut Goldschmidt, Roman Hajek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosinol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng, Douglas Joshua (2017-03-17). Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup. Leukemia & Lymphoma 58 (10) : 2501-2504. ScholarBank@NUS Repository. https://doi.org/10.1080/10428194.2017.1298755Test; http://scholarbank.nus.edu.sg/handle/10635/141100Test

    الإتاحة: http://scholarbank.nus.edu.sg/handle/10635/141100Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث